Ali Arbab
Professor
Academic Appointment(s)
Medical College of Georgia
Department of Biochemistry and Molecular Biology
Medical College of Georgia
Department of Georgia Cancer Center
The Graduate School
Bio
I have 30 years of experience in imaging science, involving MRI, SPECT, CT, ultrasound, and optical imaging modalities. My laboratory is working on to target tumor microenvironment of GBM and breast cancers using different agents and modalities
- (706) 721-8909
- (706) 434-6406
- CN3315
Education
-
Ph.D., Medical Scientist.
Yamanashi Medical University, 1998
-
MD, Medicine
University of Dhaka, 1988
Awards & Honors
-
Grant Reviewer
The National Institutes of Health, 2020
-
Grant reviewer
California Institute of Regenerative Medicine, 2017
-
Travel Award
Radiological Society of North America (RSNA), 2008
-
Fellows Award for Research Excellence (FARE)
The National Institutes of Health, 2003
-
Asia-Oceania Young Investigator’s Award
Japanese Society of Nuclear Medicine, 1999
Courses Taught Most Recent Academic Year
-
BCMB 8201
Cur Topics & Tech in MB
-
BIOM 8215
Fundamentals of Oncology I
-
BCMB 9210
Investigation of Problem
-
BCMB 9010
Seminar in BMB
-
BCMB 8340
Elements of Scientific Pres
Scholarship
Selected Recent Publications
- Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice., 2020
Journal Article, Academic Journal
- CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint., 2020
Journal Article, Academic Journal
- Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application., 2019
Journal Article, Academic Journal
- CYP4A/20-HETE regulates ischemia-induced neovascularization via its actions on endothelial progenitor and preexisting endothelial cells., 2019
Journal Article, Academic Journal
- Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model., 2019
Journal Article, Academic Journal
Research Interests
> Generation of engineered exosomes to initiate ADCC of targeted cells by NK cells.
> Ultrasound mediated delivery of exosomes
> Understanding the mechanisms of resistance to antiangiogenic treatment in solid tumors.
> Targeting arachidonic acid metabolites for the treatment of solid tumors.
>Tumor cell-secreted exosomes in modulating tumor microenvironment and niche for distal metastasis.
> Generation of tissue-specific MRI and SPECT contrast agents and drug delivery systems (nanoparticles).
University Service
-
Mock Study Section
2019 - 2020
Role: Administrative Assignment, Other
-
Steering Committee
2019 - 2020
Role: Committee Member
Professional Service
